Master of Science / Department of Biology / A. Lorena Passarelli / Cydia pomonella granulovirus (CpGV) is a member of the Baculoviridae family of viruses. The CpGV open reading frame 46 (CpGV-ORF46) predicts a 545 amino acid protein that shares homology with matrix metalloproteases (MMPs), a family of zinc-dependent endopeptidases that degrade extracellular matrix proteins. In silico analyses revealed the presence of putative mmp genes in all species from the Betabaculovirus genus, while no mmps were identified in members of the Alphabaculovirus, Gammabaculovirus or Deltabaculovirus genera. Unlike most cellular MMPs, baculovirus MMPs do not have a propeptide domain, a domain involved in regulating MMP activation, or a hemopexin-like domain, which is necessary for substrate binding and specificity in many MMPs. However, Betabaculovirus MMPs do contain a predicted conserved zinc-binding motif (HEXGHXXGXXHS/T) within their catalytic domain. The function of CpGV-MMP and its effects on baculovirus replication in cultured cells and insect larvae were investigated. CpGV-MMP was expressed in and purified from Escherichia coli, and activity was measured using a generic MMP substrate in vitro. CpGV-MMP had in vitro activity and its activity was specifically inhibited by MMP inhibitors. To study the effects of CpGV-MMP on virus replication and dissemination, CpGV-MMP was expressed from Autographa californica nucleopolyhedrovirus (AcMNPV) under the control of a strong and constitutive promoter, the Drosophila heat shock 70 protein promoter. Expression of CpGV-MMP did not affect virus replication in cultured cells. The effects of expressing CpGV-MMP from AcMNPV during larval infection were evaluated in the presence or absence of the AcMNPV chitinase and cathepsin genes. Insect bioassays showed that the absence of cathepsin resulted in a significant delay in larval time of death; however, this delay was compensated by expression of CpGV-MMP. In addition, larval time of death was accelerated when cathepsin, chitinase, and CpGV-MMP were all expressed. Finally, we determined the effects of CpGV-MMP on larvae melanization and liquefaction. CpGV-MMP was able to promote larvae melanization in the absence of cathepsin. CpGV-MMP, in the absence of cathepsin, was not able to promote larvae liquefaction. When chitinase was engineered to be secreted from cells, CpGV-MMP rescued liquefaction in the absence of cathepsin. In conclusion, CpGV-MMP is a functional MMP which can enhance larvae mortality with the presence of cathepsin. In addition, CpGV-MMP can promote larvae melanization; however, it can only promote liquefaction when chitinase is engineered to be secreted from cells.

Abstract Cancer progression is a complex multi-step process. Two critical steps in tumor growth and invasion are the proteolytic processing of the extracellular matrix environment and the angiogenic switch enabling blood supply into the tumor. Matrix metalloproteases (MMPs) are a group of proteolytic enzymes involved in physiological and pathological extracellular matrix processing. Trypsinogen, a serine protease, is one of the first proteolytic enzymes characterized. The amount of one of its isoforms, tumor associated trypsinogen-2 (TAT-2) correlates with the malignant phenotype of several forms of cancers. Both of these protease groups are critically dependent on their activation from latent proforms to fully active enzymes. We found that the overproduction of TAT-2 in malignant oral squamous cell carcinoma cell line was associated with elevated proMMP-9 (but not proMMP-2) activation, as well as enhanced cancer cell intravasation in an in vivo model. This indicates that TAT-2 and MMP-9 activation play a role in the invasive growth of oral carcinomas. Proteases are involved in angiogenesis, the formation of new blood vessels, in several ways. One mechanism is the release of cryptic anti-angiogenic molecules from larger extracellular matrix components. Endostatin is one such cryptic endogenous inhibitor of angiogenesis. Certain MMPs were able to cleave endostatin from its parent molecule, collagen XVIII. The endostatin fragments generated by MMP-3, -7, -9, -13 and -20 inhibited angiogenesis in a similar fashion as the native endostatin. The regulation between MMPs and endostatin was shown to be reciprocal, as endostatin was able to block the activation and activities of MMP-2, -9 and -13. The inhibition of these tumor-associated MMPs explains at least in part the anti-tumor activity of endostatin. Endostatin not only affects endothelial cell growth as is usually thought, but it also inhibits the migration of oral carcinoma cells. In addition, cell density and proper concentration were proven to be critical for the activity of endostatin. Arresten is another endogenous inhibitor of angiogenesis and tumor growth derived from type IV collagen. We confirmed that arresten binds to integrin α1β1 on endothelial cell surface. We found that this binding is functionally significant for the anti-angiogenic properties of arresten, as tumors planted to integrin α1 knockout mice or endothelial cells derived from those mice did not respond to arresten treatment.

LIM kinase 1 (LIMK1) is a unique dual specificity serine/threonine kinase containing two N-terminal LIM domains in tandem, a PDZ domain and a C-terminal catalytic domain. LIMK1 is involved in modulation of actin cytoskeleton through inactivating phosphorylation of the ADF (actin depolymerization factor) family protein cofilin. Recent studies have shown that LIMK1 is upregulated in breast and prostate cancer cells and tissues, promotes metastasis in animals and induces acquisition of an invasive phenotype when ectopically expressed in benign prostate epithelial (BPH) cells. Furthermore, overexpression of LIMK1 was associated with altered sub cellular localization of the membrane type 1 matrix metalloprotease (MT1-MMP). Matrix metalloproteases (MMPs) are a family of zinc dependant proteolytic enzymes that hydrolyze extra cellular matrix and cell surface molecules. A number of MMPs including MMP-2, MMP-9 and their activator MT1-MMP are over expressed in a variety of cancers including prostate cancer. The abundant expression of these enzymes contributes to changes in the tumor microenvironment, which facilitate degradation of the surrounding collagen matrix and migration of cells through the matrix defects. In this study, we show that MMPs are involved in LIMK1 induced invasion of otherwise non-invasive BPH cells. We also show that (a) the kinase activity of LIMK is not essential for the invasive behavior of the cells and (b) the absence of LIM domains significantly retards cell invasion. We have established transfected sub lines of BPH cells stably expressing 1) constitutively active LIMK1 (BPHLCA), 2) kinase dead LIMK1 (BPHLKD) and 3) only the kinase domain of LIMK1 (BPHLK) for our study. In vitro invasion assays revealed that LIMK1 induced invasion was inhibited by the MMP specific inhibitor, GM6001, and that cells expressing kinase-dead LIMK1 were equally invasive. Furthermore, BPH cells expressing LIMK1 mutants expressed higher amounts of MMP-2 and MMP-9. Substrate zymography revealed increased concentration of secreted MMP-2 and MMP-9 in the media of BPHLCA and BPHLK cells respectively compared to BPHV (vector control) cells. Quantitative RT-PCR also showed a ~10 fold increase in the steady state concentration of MMP-2 in BPHLCA cells compared to the control BPHLV cells. Expression of active LIMK1 stimulated cell-surface expression of MT1-MMP in BPHLCA cells as determined by flow cytometry. A modest increase in expression of MT1-MMP was noted in BPHLKD cells compared to BPHLK and BPHV cells. Immunoflourescence analysis indicated differential localization of MT1-MMP and LIMK1 in BPH cells expressing different mutants of LIMK1. Co-localization of LIMK1 and MT1-MMP in the plasma membrane and in the perinuclear region was also evident in these cells. Furthermore, here we provide evidence that suggests a functional role for phosphorylated (activated) LIMK1/2 (p-LIMK1/2) during mitosis through its association with γ-tubulin. Immunoflourescence analysis showed distinct co-localization of γ -tubulin and p-LIMK1/2 in the centrosomes during mitosis from early prophase to the beginning of telophase. No association was seen in the interphase or in late telophase. Phospho-LIMK1/2 was co-precipitated in immunoprecipitates of γ -tubulin using an anti- γ -tubulin antibody suggesting a physical association between these proteins in a complex. This finding reveals a novel role of LIMK1 in the mitotic process. In summary, our data suggests that MMPs are involved in LIMK1 induced invasion of prostate epithelial cells, and that this effect is mediated through altered expression and activation of specific MMPs. Furthermore, LIMK1 induced invasion is dependant on the presence of LIM domains more than the kinase activity. Finally, we show that phosphorylated LIMK1 and LIMK2 are involved in the mitotic process in a stage specific manner through its association with the centrosomal protein γ -tubulin. Because LIMK1 promotes invasion in vitro, regulates expression of MMPs, and is involved in mitotic processes, it is an attractive drug target for prostate cancer therapy.

A radioterapia é um dos principais tratamentos para pacientes com câncer de cabeça e pescoço e a cárie relacionada à radioterapia é um de seus efeitos colaterais, apresentando-se com alta taxa de ocorrência. Além disso, falhas precoces em restaurações realizadas em dentes de pacientes irradiados em cabeça e pescoço também são observadas. Como a degradação enzimática do colágeno ocorre principalmente através da atividade das metaloproteinases de matriz e das cisteínacatepsinas, o objetivo deste estudo foi avaliar a atividade enzimática da dentina hígida e restaurada de dentes submetidos à radioterapia in vivo e in vitro. Os dentes irradiados in vivo foram extraídos de pacientes submetidos à radioterapia com uma dose cumulativa que variou de 40 a 70 Gy. As extrações foram feitas de 3 a 12 meses após a RT devido a doenças periodontais. Para os dentes irradiados in vitro, as amostras foram submersas em água destilada com uma irradiação total e única de 70 Gy. O estudo foi dividido em 2 fases independentes: Fase 1: Dentina Não-Restaurada (avaliação de amostras não irradiadas, dentes submetidos à radioterapia in vitro e in situ). Fase 2: Dentina Restaurada (avaliação de amostras não irradiadas e dentes submetidos à radioterapia in vitro) com 3 adesivos. Para o ensaio de zimografia (fase 1), os grupos irradiados in vitro, in vivo e não irradiados foram divididos em dois subgrupos: 1) mineralizado; 2) desmineralizado com ácido fosfórico10%. As proteínas dentinárias foram extraídas e submetidas à análise zimográfica de acordo com Mazzoni et al., 2007. Para a zimografia in situ (fase 2), os espécimes foram divididos em 6 grupos, de acordo com a forma de irradiação (não irradiada e irradiada in vitro) e o sistema adesivo testado (Adper Single Bond, 3M ESPE, ClearFil SE Bond, Kuraray ou Scotchbond Universal, 3M ESPE). Uma gelatina conjugada com fluoresceína autoextinguível foi usada como substrato para as proteases endógenas. A atividade enzimática gelatinolítica foi observada em microscópio confocal (Zeiss LSM 780-NLO, Carl Zeiss Microscopy GmbH). Para a análise da microscopia eletrônica de varredura, amostras restauradas e hígidas foram submetidas a técnica de pré-imunomarcação usando anticorpo monoclonal primário anti-CT-K e anti-CT-B, e anticorpo secundário conjugado com nano-partículas de ouro de 15nm. Um aumento na atividade gelatinolítica pós radioterapia para ambos os substratos (dentina restaurada e hígida) pôde ser observada. Houve uma maior expressão das formas ativas das MMP-2 e MMP-9 pós radioterapia para ambas as formas de radioterapia em dentina não restaurada. Nenhuma diferença na imuno-marcação para CT-K e CT-B entre os grupos irradiados e não irradiados foi observada. Adesivos autocondicionantes apresentaram uma imuno-marcação mais fraca para CT-K quando comparado ao adesivo de condicionamento total. Com isso, pode-se concluir que a radiação ionizante foi capaz de influenciar a atividade enzimática das proteínas endógenas da dentina restaurada e não restaurada. Palavras-chave: Radioterapia, metaloproteinases de matriz, MMP, cisteinocatepsinas, CT, Cárie relacionada à radiação. / Radiotherapy is one of the main treatments for head and neck cancer patients. Radiation-related caries and early restorations failures are side-effects with high rate of recurrence. As enzymatic degradation of collagen occurs mainly through the activity of matrix metalloproteinases (MMPs) and cysteine-cathepsins (CTs), the objective of this study was to evaluate the influence of in vivo and in vitro radiotherapy on endogenous proteases of the restored and non-restored dentin. In vivo irradiated teeth were extracted from patients who underwent clinical radiation protocols with a cumulative dose of radiation that ranged from 40 to 70 Gy. Extractions were performed 3 to 12 months after radiotherapy conclusion due to periodontal reasons. For the in vitro irradiated teeth, samples were submerged in distilled water with a total and single irradiation dose of 70 Gy. For gelatin zymography assay, irradiated in vivo, in vitro and non-irradiated groups were divided in two subgroups: 1) mineralized or 2) demineralized with 10% phosphoric acid. Dentin proteins were extracted and submitted to zymographic analysis in accordance to Mazzoni et al., 2007. For in situ zymography, specimens were divided into 6 groups, according to its irradiation form (non-irradiated and irradiated in vitro) and the adhesive system tested (Adper Single Bond, 3M ESPE, ClearFil SE Bond, Kuraray or Scotchbond Universal, 3M ESPE) using a self-quenched fluorescein-conjugated gelatin as the endogenous proteases substrate. The endogenous gelatinolytic enzyme activity was assessed by confocal laser-scanning microscope (Zeiss LSM 780-NLO, Carl Zeiss Microscopy GmbH). For SEM analysis of the HL, restored specimens were submitted to a pre-embedding immunolabeling technique using primary monoclonal antibody anti-CT-K and anti-CTB and a secondary antibody conjugated with 15nm gold nanoparticles. Radiotherapy groups presented increased gelatinolytic activity on both restored and non-restored dentin. MMP-2 and MMP-9 active form presented higher expression on both irradiated groups for non-restored dentin. Labeling for CT-K and CT-B did not differ from irradiated to non-irradiated groups. SE adhesives presenter weaker labeling for CT-K when compared to the E&R adhesive. Herewith, ionizing radiation may be able to influence the enzymatic activity of the endogenous proteins of restored and unrestored dentin

Metastasis is the main cause of death from solid cancer. The dissemination of cancer cells from a primary tumour is a very complex process that involves many steps and cells must overcome many obstacles to colonize distant organs. The tumour microenvironment influences the mode and the dynamics of invasion of cancer cells. Cancer cells have the ability to adapt to distinct environmental conditions in order to stay motile. Invasive cancer cells form membrane protrusions called invadopodia that are able to degrade extracellular matrix. The formation of invadopodia by cancer cells is interconnected to the production of matrix metalloproteases (MMPs). Metastasizing tumour cells use MMPs to break through extracellular matrix barriers and migrate in dense matrix. Both invadopodia formation and MMPs secretion is crucial for the degradation of the extracellular matrix. The most important is the membrane bound MMP-14 (MT1-MMP) and soluble MMP-2 and MMP-9. The invasive structures of tumour cells and the proteolytic enzymes in 2D environment is well described. However, a suitable model of localization and transport of MMPs and connection with invadopodia of tumour cells in 3D environment is still lacking. This diploma thesis focused on the extension of current knowledge of these key MMPs and on the...

Abstract The tumor microenvironment (TME) is critically important for tumor development. The microenvironment consists of fibroblasts, endothelial and immune cells as well as extracellular matrix (ECM), proteases and various other soluble factors produced by the cells. It is challenging to develop methods that appropriately mimic the human microenvironment, but this effort is essential in order to reliably elucidate the properties of potential anti-tumor drugs. The aim of this study was to create new 3D organotypic invasion models based on human tissue that would be used to study the effects of the anti-angiogenic molecules arresten and endostatin on tongue squamous carcinoma cells. The classic way to study cancer invasion has been to use a collagen invasion model that is created by mixing rat type I collagen, matrix produced by mouse EHS tumor cells and human fibroblasts. Our research group has developed a novel human myoma tissue based invasion model, which is composed of several different cell types and molecules that are normally present in the human TME. We show how this model is suitable for invasion studies, not only for oral cancer, but for other invasive cell lines as well. There are several matrix-derived fragments that have been shown to possess anti-angiogenic activity. Arresten is a 26 kDa fragment that is cleaved from type IV collagen and is known to inhibit angiogenesis, the formation of new capillaries and tumor growth in vivo. However, its effect on the tumor microenvironment in addition to endothelial cells has not been studied. We show that arresten also directly affects oral cancer cells by decreasing their migration and invasion as well as tumor size, invasion and angiogenesis in in vivo mouse xenografts. Another inhibitor of angiogenesis, endostatin, is cleaved from type XVIII collagen. It has been shown to suppress angiogenesis and tumor growth without toxicity or side effects in mouse models. Our studies show that endostatin directly affects tongue squamous carcinoma cells by reducing their invasion and spreading in organotypic 3D assays and mouse tumor models. In summary, arresten and endostatin are anti-angiogenic as well as anti-invasive molecules and therefore potential cancer drugs. They seem to have a direct effect on carcinoma cells making the cells less invasive. The myoma model allows us to study the effects of anti-cancer molecules with a new prospective. / Tiivistelmä Syövän mikroympäristö on erittäin tärkeä syövän kehittymisen kannalta. Se koostuu fibroblasteista, endoteeli- ja immuunisoluista, soluväliaineesta, proteaaseista ja monista muista solujen tuottamista liukoisista molekyyleistä. On haastavaa kehittää uusia menetelmiä, jotka jäljittelisivät oikeaa ihmisen syövän mikroympäristöä, mutta se on välttämätöntä uusien syöpälääkkeiden tutkimiseksi. Väitöstutkimuksen tavoitteena oli kehittää kolmiulotteinen ihmisen myoomakudokseen perustuvan invaasiomalli, jonka avulla voisimme tutkia verisuonten kasvua estävien arresten ja endostatin molekyylien vaikutusta kielisyöpäsoluihin. Aiemin syövän invaasiota on tutkittu käyttämällä klassista kollageeni-invaasiomallia, joka tehdään sekoittamalla rotan tyypin I kollageeniä, hiiren sarkoomasolujen tuottamaa matriksia ja ihmisen fibroblasteja. Tutkimuksissamme kehitimme uuden invaasiomallin, joka perustuu ihmisen myoomakudokseen. Tutkimuksessa sen todettiin sisältävän monia erilaisia soluja ja molekyylejä, joita on normaalistikkin syövän mikroympäristössä. Lisäksi osoitimme, että se sopii invaasiotutkimuksiin monille syöpätyypeille. Soluvälitilamatriksista pilkotaan useita erilaisia molekyylejä joilla on osoitettu olevan angiogeneesia hillitseviä ominaisuuksia. Arresten on 26 kDa kokoinen polypeptidi, jota pilkotaan tyypin IV kollageenista. Sen tiedetään vähentävän angiogeneesia – uusien verisuonten muodostumista ja syövän kasvua in vivo. Sen vaikutuksia muihin kuin endoteelisoluihin ei ole kuitenkaan tutkittu. Tutkimuksissamme se vaikutti suoraan kielisyöpäsoluihin vähentäen niiden liikkumista ja invaasiota kolmiulotteisissa organotyyppisisssä malleissa ja hiirimallissa. Toinen tutkimamme angiogeneesin inhibiittori on endostatin, jota pilkotaan tyypin XVIII kollageenista. Sen tiedetään vähentävän angiogeneesia hiirimalleissa ilman toksisia sivuvaikutuksia. Me osoitimme tutkimuksissamme, että se vaikuttaa suoraan kielisyöpäsoluihin vähentäen niiden invaasiota ja leviämistä 3D organotyyppisissä malleissa sekä hiirikokeissa. Koska arresten ja endostatin ovat anti-angiogeenisiä ja anti-invasiivisia molekyylejä, ne ovat täten potentiaalisia syöpälääkkeitä. Ne näyttäisivät vaikuttavan suoraan syöpäsoluihin vähentämällä niiden invaasiota. Myoomainvaasiomalli mahdollistaa syöpää ehkäisevien molekyylien tutkimisen uudella ja todenmukaisemmalla tavalla.

Le développement d’une nouvelle sonde dite « activity-based probe » pour réaliser la détection de formes actives de protéases appartenant à la famille des protéases à zinc de la matrice (MMP) a été réalisé dans ce travail, en partant d’un inhibiteur phosphinique puissant des MMP dans lequel a été introduit un groupement photoactivable de type diazérine. Ce composé se révèle un inhibiteur puissant de plusieurs MMP avec des affinités nanomolaires. Ce composé incubé avec différentes MMP est par ailleurs capables de modifier de façon covalente un grand nombre de MMP au niveau de leur site actif, avec des rendements de modification variant de plus de 50% à 11%, selon la nature des MMP. En ayant choisi comme moyen de détection la radioactivité, nous démontrons qu’avec cette nouvelle sonde qu’il est possible de détecter des formes actives de MMP avec des sensibilités de l’ordre de la femtomole dans des systèmes modèles de protéomes complexes. Appliquée à l’analyse de lavages broncho alvéolaires de souris traitées par voie pulmonaire avec des nanoparticules pour induire une réponse inflammatoire, cette nouvelle sonde permet de mettre en évidence la présence de formes actives du domaine catalytique de la MMP-12, une métalloprotéase à zinc exprimée par les macrophages, mais pas dans les animaux contrôles. En revanche l’analyse de carotides humaines de patients souffrant d’athérosclérose ne nous pas conduit avec cette sonde à la détection de formes actives de MMP. Malgré ce résultat, il est à noter que la détection de forme active de MMP dans un fluide pathologique est une première dans ce domaine. Cette sonde étant validée pour sa capacité à détecter des formes actives de MMP, elle permettra dans l’avenir de tester d’autres fluides pathologiques d’origine humaine ou bien des extraits de tissu comme des tumeurs pour lesquels les MMP pourraient être des marqueurs de ces pathologies. / A new activity-based probe able to covalently modify the active site of proteases belonging to the matrix metalloprotease family (MMPs) has been developed in this thesis project. The probe was shown to behave as potent inhibitor of several MMPs, with nanomolar Ki values. This probe was also able to modify specifically only the free active site of MMPs, with particular high yields of cross-linking varying from 50 % to 11 %, depending of the MMPs tested. Using radioactivity as means of detection, this probe was able to detect active form of MMPs with a threshold of 1 femtomole. Applied to the study of bronchoalvelolar fluids (BAL) from mice exposed to nanoparticles by a lung aspiration protocol, this probe revealed the presence of the catalytic domain of MMP-12 under its active form, but not in control animals. When used to detect active form of MMPs from extracts obtained from human arteries of patient suffering from atherosclerosis, the probe was not able to detect such MMP active forms. Despite this negative result, the detection of active form of MMP in pathological fluid like BAL has never been reported before this work. Having validated this novel MMP activity-based probe, it will be possible to use it now for detecting MMPs from other pathological fluids or tissues extracts in which MMPs can be good markers of the pathology.

No description available.